Ignite Creation Date:
2025-12-25 @ 2:41 AM
Ignite Modification Date:
2026-03-01 @ 11:59 PM
Study NCT ID:
NCT03705533
Status:
COMPLETED
Last Update Posted:
2018-12-27
First Post:
2018-10-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioequivalence Study of Two Formulations of Telmisartan 80 mg Tablets in Healthy Adult Volunteers Under Fasting State
Sponsor:
Pharmtechnology LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-09-07
Start Date Type:
ACTUAL
Primary Completion Date:
2018-12-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-12-19
Completion Date Type:
ACTUAL
First Submit Date:
2018-10-08
First Submit QC Date:
None
Study First Post Date:
2018-10-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-12-26
Last Update Post Date:
2018-12-27
Last Update Post Date Type:
ACTUAL